RxDoctor Payments Data

Diane Kepner, MD

Family Medicine · York, PANPI 1487626461

Payments from drug & device makers

$1,883in general payments, 2019–2025

Across 88 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$292
  • Novo Nordisk$246
  • AbbVie$215
  • Lilly USA, LLC$207
  • Pfizer$203
  • Abbott$67
  • plus $653 from 17 others

What the payments were for

  • Food & beverage$1,883100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,883 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$251,095
Medicare patients
405
Services billed
7,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$49,244
FarxigaDapagliflozin Propanediol39$48,573
JardianceEmpagliflozin29$44,296
EliquisApixaban26$43,055
XareltoRivaroxaban11$14,421
MounjaroTirzepatide14$13,128
TrulicityDulaglutide13$11,240
Rosuvastatin Calcium157$3,473
Atorvastatin Calcium246$3,224
Bupropion XlBupropion Hcl28$2,470
Levothyroxine Sodium187$2,252
Ezetimibe39$1,950
Metoprolol Succinate81$1,843
Colesevelam Hcl11$1,703
Valsartan49$1,679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$246$49,24440 claims
AstraZenecaFarxiga$66$48,57339 claims
Boehringer IngelheimJardiance$50$44,29629 claims
PfizerEliquis$203$43,05526 claims
Lilly USA, LLCMounjaro, Trulicity$207$24,36827 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$18$2,252187 claims
AbbVieSynthroid$215$78126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →